New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 2006 Aug;28(4):181-7
Date
08/25/2006Pubmed ID
16927637Scopus ID
2-s2.0-33746754723 (requires institutional sign-in at Scopus site) 30 CitationsAbstract
The annual incidence of testicular neoplasms has doubled in the last 40 years, with an estimated 7,500 new cases of germ cell tumor each year. The role of immunostaining has increased with the introduction of several novel markers in the last decade. The role of the following markers in differential diagnosis is featured: alpha-fetoprotein, c-kit, CD30, cytokeratin AE1/3, glypican-3, human chorionic gonadotropin, OCT3/4, NANOG, p63, placental-like alkaline phosphatase, topoisomerase II, and VASA.
Author List
Iczkowski KA, Butler SLMESH terms used to index this publication - Major topics in bold
Biomarkers, TumorDiagnosis, Differential
Humans
Immunohistochemistry
Male
Sensitivity and Specificity
Testicular Neoplasms